AIDS vaccine technology brief

Article Abstract:

Cel-Sci has undertaken to develop a preventive vaccine against AIDS to end the epidemic of HIV infection and AIDS, especially in developing countries. Dr Prem Sarin has been designated as the scientific head of the Cel-Sci team tasked with developing an AIDS vaccine. Sarin is equipped with the knowledge and training for the job, given his experience at private, academic and government institutions, such as Harvard and George Washington University, the National Institutes of Health and Merck, Sharp & Donne. He cites world politics as one of the roadblocks in moving vaccine development forward.

Product development, Biotechnology industry, Biotechnology industries, Social policy, AIDS vaccines, Sarin, Prem, CEL-SCI Corp., CELID

---

New pertussis vaccine approved

Article Abstract:

The FDA has licensed North American Vaccine to manufacture and market a new diphtheria-tetanus-acellular pertussis vaccine. The National Institute of Child Health and Human Development (NICHD) has licensed to North American Vaccine its patent for producing the pertussis vaccine, whose pertussis component was developed in Dr John Robbins' NICHD laboratory. Registered as Certiva, the vaccine consists of only a single antigen, pertussis toxoid, compared to others that have multiple pertussis antigens.

Prevention, Vaccines industry, Biological products industry, Licensing agreements, North American Vaccine Inc., NVX, Whooping-cough, Whooping cough, Pertussis vaccines

---

Similar abstracts:

• Abstracts: Clinical ecology. NIH support for basic and clinical research
• Abstracts: Supplying the vaccine. The quest for a vaccine. Third World vaccine production: vaccine producers in the developing countries have an important role to play in supplying high-quality products, and their efforts need to be supported by both the public and private sectors
• Abstracts: AIDS and school education. Ritual and culture. Culture and preventative care at school: Geneva
• Abstracts: Send in the clowns. Just what we needed. Send in the clones
• Abstracts: Opiate dependency among the subscribers of a New York area private insurance plan

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.